Biotechnology Published Insights

Published Date : 27 Aug, 2026

The Autologous Stem Cell And Non-Stem Cell Based Therapies Market is anticipated to grow at a CAGR of 14.8% with USD 6.9 Bn in 2026 and is expected to reach USD 14.2 Bn in 2033. The autologous stem cell and non-stem c... View more

Published Date : 26 Aug, 2026

The Biosimilar Pipeline Analysis Market is estimated to be valued at USD 40.25 Bn in 2026 and is expected to reach approximately USD 120.79 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 17% from 2026 ... View more

Published Date : 24 Aug, 2026

The global transduction enhancer reagents market is estimated to be valued at USD 119.5 Mn in 2026 and is expected to reach USD 210.5 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.4%... View more

Published Date : 17 Aug, 2026

The global bioink market is estimated to be valued at USD 218.6 Mn in 2026 and is expected to reach USD 751.9 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 19.3% from 2026 to 2033. Bi... View more

Published Date : 13 Aug, 2026

The Organ Transplant Market is anticipated to grow at a CAGR of 7.8% with USD 9.1 Bn in 2026 and is expected to reach USD 17.7 Bn in 2033. Organ transplantation provides a critical treatment for patients with end-stag... View more

Published Date : 13 Aug, 2026

The U.S. pharmacogenomics market is estimated to be valued at USD 5,803.3 Mn in 2026 and is expected to reach USD 13,930.7 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 13.3% from 2026 to 2033. Pharma... View more

Published Date : 13 Aug, 2026

The global biopharmaceutical environmental monitoring market is estimated to be valued at USD 2,235.9 Mn in 2026 and is expected to reach USD 3,864.2 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.1%... View more

Published Date : 10 Aug, 2026

The Diabetes Vaccine Market is estimated to be valued at USD 89.6 Mn in 2026 and is expected to reach USD 153.3 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8% from 2026 to 2033. The market is underg... View more

Published Date : 06 Aug, 2026

The Europe, U.S., and India liquid biopsy market is estimated to be valued at USD 169.2 Mn in 2026 and is expected to reach USD 535.2 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 17.9% from 2026 to 2... View more

Published Date : 06 Aug, 2026

The North America and Europe plasmid DNA manufacturing market is estimated to be valued at USD 1,780.2 Mn in 2026 and is expected to reach USD 12,053.9 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 31.4% ... View more

Published Date : 04 Aug, 2026

The global adult mesenchymal stem cells for orthopedics market are estimated to be valued at USD 195.0 Mn in 2026 and is expected to reach USD 382.3 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 10.1%... View more

Published Date : 04 Aug, 2026

The hepatitis vaccine market is estimated to be valued at USD 3.51 Bn in 2026 and is expected to reach USD 4.50 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 3.63% from 2026 to 2033. The hepatitis vac... View more

Published Date : 03 Aug, 2026

The Bacillus Subtilis Market is estimated to be valued at USD 6.21 Bn in 2026 and is expected to reach approximately USD 7.94 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 3.6% from 2026 to 2033. The ... View more

Published Date : 30 Jul, 2026

The Blood Clotting Factors Market is estimated to be valued at USD 7.43 Bn in 2026 and is expected to reach USD 13.42 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033. The market i... View more

Published Date : 30 Jul, 2026

The Oncology Biosimilars Market is estimated to be valued at USD 9.7 Bn in 2026 and is expected to reach USD 28.5 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 16.6% from 2026 to 2033. The market is u... View more

Published Date : 30 Jul, 2026

The global medical grade chitosan market is estimated to be valued at USD 430.5 Mn in 2026 and is expected to reach USD 921.9 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 11.5% from ... View more

Published Date : 29 Jul, 2026

The global enzyme, peptide and MAB therapeutics market is estimated to be valued at USD 425,918.7 Mn in 2026 and is expected to reach USD 982,657.9 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of ... View more

Published Date : 28 Jul, 2026

The Immune Anti-Inhibitor market is estimated to be valued at USD 5.6 Bn in 2026 and is expected to reach USD 9.8 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.2% from 2026 to 2033. The market is un... View more